Grateful Patients Praise Hadassah Medical Organization
Whether it is from a pregnant woman needing to spend part of her pregnancy as an inpatient or a cancer patient receiving chemotherapy, the Hadassah University Medical Center receives letters of appreciation on a daily basis.
“When I was pregnant, I was admitted for observation to Maternity B at Hadassah Hospital-Mount Scopus for 10 days. I met a kind, professional, calm, attentive, and practical nursing team, who gave an immediate response to every question or request. I don't think one can overemphasize the importance of the above-mentioned qualities in a situation where a pregnant woman has to spend part of her pregnancy in a hospital under close observation. Yasher coach(Congratulations) to all the staff and especially each and every nurse who literally escorted me on Maternity B.”--L.S.
“I would like to thank the entire team at the oncology day care center for outstanding work, their devotion to the patients, and all the good things that happened there to my sister during a very long and difficult cycle of chemotherapy. She received excellent treatment, and I will not mention names in order not to miss anyone. But Dr. David Edelman deserves a special huge thank you for bringing her to believe again that there was still hope, and that she was not going to die within four months as she was told in another hospital. It was a very difficult year for us--treatments and repeated travel from northern Israel to Jerusalem and back. I am proud for you that you have such a dedicated team. I am so happy that you gave me my sister back--with a major remission in her condition and normal-level markers.”—M.S.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>